NSN 6505-01-642-0106 · NIIN 016420106 · FSC 6505
NO DASHES 6505016420106
In Stock
ADENOVIRUS TYPE 4 AND TYPE 7 VAC
Drugs and Biologicals
Technical characteristics
2 rows
Straight from the federal item record. Entries the record leaves empty are shown empty — nothing is filled in on its behalf.
| MRC | Requirement | Value |
|---|---|---|
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | ADENOVIRUS TYPE 4 AND TYPE 7 VACCINE LIVE ORAL ENTERIC COATED TABLETS 200S |
| FEAT | SPECIAL FEATURES | CONTAINS VIABLE, SELECTED STRAINS OF HUMAN ADENOVIRUS TYPE 4 AND HUMAN ADENOVIRUS TYPE 7 PREPARED IN HUMAN-DIPLOID FIBROBLAST CELL CULTURES (STRAIN WI-38); VIRUS STRAINS HAVE NOT BEEN ATTENUATED; CELLS ARE GROWN AND THE VIRUS GROWTH MAINTAINED IN DULBECCO'S MODIFIED EAGLE'S MEDIUM, FETAL BOVINE SERUM, AND SODIUM BICARBONATE; APPROVED FOR USE IN MILITARY POPULATIONS 17-50 YEARS OF AGE; INDICATED FOR ACTIVE IMMUNIZATION FOR THE PREVENTION OF FEBRILE ACUTE RESPIRATORY DISEASE CAUSED BY ADENOVIRUS TYPE 4 AND TYPE 7; CARTON CONSISTS OF ONE BOTTLE OF 100 TABLETS ADENOVIRUS TYPE 4 (NDC 51285-174-02) AND ONE BOTTLE OF 100 TABLETS ADENOVIRUS TYPE 7 (NDC 51285-175-02); STORE REFRIGERATED BETWEEN 2-8 DEG C (35-46 DEG F); DO NOT FREEZE; KEEP BOTTLE TIGHTLY CLOSED AND PROTECT FROM MOISTURE; DO NOT REMOVE DESICCANT CANISTER FROM BOTTLE; PRESCRIPTION ONLY; FOR ORAL ADMINISTRATION; DOSAGE: ONE TABLET OF ADENOVIRUS TYPE 4 COMPONENT AND ONE TABLET OF ADENOVIRUS TYPE 7 COMPONENT |